BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Diagnosis
61 results:

  • 1. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
    Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
    Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique.
    Liu K; Cui Y; Li H; Mi J; Wang H; Zhuang Y; Tang L; Liu J; Tian C; Zhang Z; Zhou J; Shi H; Tian X; Liu P
    Crit Rev Oncol Hematol; 2023 Aug; 188():104057. PubMed ID: 37328085
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.
    Xu Y; Zhang X; Zhang R; Sun Y; Liu J; Luo C; Yang J; Fang W; Guo Q; Wei L
    Cancer Lett; 2023 Jul; 566():216240. PubMed ID: 37217071
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A literature review of microRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer.
    Abolfathi H; Arabi M; Sheikhpour M
    Respir Res; 2023 Feb; 24(1):55. PubMed ID: 36800962
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluating the Expression and Prognostic Value of Genes Encoding Microtubule-Associated Proteins in lung cancer.
    Singharajkomron N; Yodsurang V; Seephan S; Kungsukool S; Petchjorm S; Maneeganjanasing N; Promboon W; Dangwilailuck W; Pongrakhananon V
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499051
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population.
    Heredia D; Mas L; Cardona AF; Oyervides V; Motta Guerrero R; Galvez-Nino M; Lara-Mejía L; Aliaga-Macha C; Carracedo C; Varela-Santoyo E; Ramos-Ramírez M; Davila-Dupont D; Martínez J; Cruz-Rico G; Remon J; Arrieta O
    Lung Cancer; 2022 Dec; 174():133-140. PubMed ID: 36379126
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A progressive and refractory case of breast cancer with Cowden syndrome.
    Sueta A; Takeno M; Goto-Yamaguchi L; Tomiguchi M; Inao T; Yamamoto-Ibusuki M; Yamamoto Y
    World J Surg Oncol; 2022 Sep; 20(1):279. PubMed ID: 36057718
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC.
    Baine MK; Febres-Aldana CA; Chang JC; Jungbluth AA; Sethi S; Antonescu CR; Travis WD; Hsieh MS; Roh MS; Homer RJ; Ladanyi M; Egger JV; Lai WV; Rudin CM; Rekhtman N
    J Thorac Oncol; 2022 Sep; 17(9):1109-1121. PubMed ID: 35760287
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multiple metastases of androgen indifferent prostate cancer in the urinary tract: two case reports and a literature review.
    Masuda T; Kosaka T; Nakamura K; Hongo H; Yuge K; Nishihara H; Oya M
    BMC Med Genomics; 2022 May; 15(1):118. PubMed ID: 35598018
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genomic Features of lung-Recurrent Hormone-Sensitive Prostate cancer.
    Fonseca NM; Van der Eecken K; Herberts C; Verbeke S; Ng SWS; Lumen N; Ritch E; Murtha AJ; Bernales CQ; Schönlau E; Moris L; Van Dorpe J; Annala M; Wyatt AW; Ost P
    JCO Precis Oncol; 2022 Apr; 6():e2100543. PubMed ID: 35507889
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
    Entezari M; Ghanbarirad M; Taheriazam A; Sadrkhanloo M; Zabolian A; Goharrizi MASB; Hushmandi K; Aref AR; Ashrafizadeh M; Zarrabi A; Nabavi N; Rabiee N; Hashemi M; Samarghandian S
    Biomed Pharmacother; 2022 Jun; 150():112963. PubMed ID: 35468579
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Clinical and molecular pathological features of bronchopulmonary large cell neuroendocrine carcinoma].
    Meng Y; Lian YB; Xu Y; Dong JQ; Song M
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1020-1027. PubMed ID: 35399022
    [No Abstract]    [Full Text] [Related]  

  • 13. Considerations on diagnosis and surveillance measures of pten hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients.
    Pena-Couso L; Ercibengoa M; Mercadillo F; Gómez-Sánchez D; Inglada-Pérez L; Santos M; Lanillos J; Gutiérrez-Abad D; Hernández A; Carbonell P; Letón R; Robledo M; Rodríguez-Antona C; Perea J; Urioste M;
    Orphanet J Rare Dis; 2022 Feb; 17(1):85. PubMed ID: 35227301
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.
    Cardona AF; Jaramillo-Velásquez D; Ruiz-Patiño A; Polo C; Jiménez E; Hakim F; Gómez D; Ramón JF; Cifuentes H; Mejía JA; Salguero F; Ordoñez C; Muñoz Á; Bermúdez S; Useche N; Pineda D; Ricaurte L; Zatarain-Barrón ZL; Rodríguez J; Avila J; Rojas L; Jaller E; Sotelo C; Garcia-Robledo JE; Santoyo N; Rolfo C; Rosell R; Arrieta O
    J Neurooncol; 2021 Sep; 154(3):353-364. PubMed ID: 34498213
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pulmonary sclerosing pneumocytoma masquerading adenocarcinoma with co-existing BRAF V600E and pten mutation.
    Dantis K; Gupta AK; Kashyap NK; Kashyap Y; Ranganath TG; Pati SK; Kumar M; Thakur S; Ravina M
    Cancer Treat Res Commun; 2021; 28():100429. PubMed ID: 34246179
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and pten, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling.
    Di Paolo D; Pontis F; Moro M; Centonze G; Bertolini G; Milione M; Mensah M; Segale M; Petraroia I; Borzi C; Suatoni P; Brignole C; Perri P; Ponzoni M; Pastorino U; Sozzi G; Fortunato O
    Mol Oncol; 2021 Nov; 15(11):2969-2988. PubMed ID: 34107168
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Standardized uptake value (SUV
    Haghighat Jahromi A; Chang G; Kurzrock R; Hoh CK
    Cancer Biol Ther; 2020 Nov; 21(11):1067-1071. PubMed ID: 33131408
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Association of Damaging Variants in Genes With Increased cancer Risk Among Patients With Congenital Heart Disease.
    Morton SU; Shimamura A; Newburger PE; Opotowsky AR; Quiat D; Pereira AC; Jin SC; Gurvitz M; Brueckner M; Chung WK; Shen Y; Bernstein D; Gelb BD; Giardini A; Goldmuntz E; Kim RW; Lifton RP; Porter GA; Srivastava D; Tristani-Firouzi M; Newburger JW; Seidman JG; Seidman CE
    JAMA Cardiol; 2021 Apr; 6(4):457-462. PubMed ID: 33084842
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from neoplastic meningitis patients using next generation sequencing.
    Zhao Y; He JY; Cui JZ; Meng ZQ; Zou YL; Guo XS; Chen X; Wang X; Yan LT; Han WX; Li C; Guo L; Bu H
    BMC Cancer; 2020 Jul; 20(1):690. PubMed ID: 32711494
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression.
    Giroux Leprieur E; Hélias-Rodzewicz Z; Takam Kamga P; Costantini A; Julie C; Corjon A; Dumenil C; Dumoulin J; Giraud V; Labrune S; Garinet S; Chinet T; Emile JF
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581058
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.